MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Alpha Cognition Inc (OP:ACOGF)

0.3500 UNCHANGED
Last Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.3500
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.3500
Today's Range 0.3500 - 0.3500
52wk Range N/A - N/A
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Alpha Cognition Announces Proposed Financing and Share Consolidation in connection with Nasdaq Uplisting
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition Announces Appointment of VP Finance and Accounting
From Alpha Cognition Inc.
Via Business Wire

Performance

More News

Read More
News headline image
Alpha Cognition Receives Notice of Allowance for Composition-of-Matter Patent for ZUNVEYLTM for Mild to Moderate Alzheimer’s Disease
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition Announces Change of Officer
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition Announces Completion of $4.545 Million (USD) Convertible Note and Warrants Bridge Financing
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition Receives Notice of Allowance for Composition-of-Matter Patent for ZUNVEYL® for Mild to Moderate Alzheimer’s Disease
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition, Inc. On Track to Secure Financing for Continued Growth
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition’s Oral Therapy ZUNVEYL® Receives FDA Approval to Treat Alzheimer's Disease
From Alpha Cognition Inc.
Via Business Wire
News headline image
Life Science Virtual Investor Forum Presentations Now Available for Online Viewing
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Life Science Virtual Investor Forum Agenda Announced for March 7th, 2024
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Alpha Cognition to Present at the Life Science Investor Forum March 7th
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Alpha Cognition Files U.S. Patent Application Covering an ALPHA-1062 Oral Formulation to Treat Mild to Moderate Alzheimer’s Disease
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition Provides Business Update
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition Announces Final Closing of Private Placement Offering and Completion of the Overallotment
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition Announces Fourth Closing of Private Placement and Continuation of the Offering
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition Announces FDA Acceptance of New Drug Application for ALPHA-1062 for Mild-to-Moderate Alzheimer’s Disease
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition Announces Amended Terms of Private Placement and Continuation of the Offering
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition Announces Second Closing of Private Placement and Continuation of the Offering
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition Announces Initial Closing of Private Placement and Pricing for Continuation of the Offering
From Alpha Cognition Inc.
Via Business Wire
News headline image
Life Science Investor Forum: Presentations Now Available for Online Viewing
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Life Science Investor Forum Agenda Announced for June 22nd
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Alpha Cognition Launches $6.5 Million Private Placement
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition Announces Fourth Quarter and Full Year 2022 Results and Provides Corporate Update
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition Provides Private Placement Update
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition Announces Third Quarter 2022 Results and Provides Corporate Update
From Alpha Cognition Inc.
Via Business Wire

Frequently Asked Questions

Is Alpha Cognition Inc publicly traded?
Yes, Alpha Cognition Inc is publicly traded.
What exchange does Alpha Cognition Inc trade on?
Alpha Cognition Inc trades on the OTC Traded
What is the ticker symbol for Alpha Cognition Inc?
The ticker symbol for Alpha Cognition Inc is ACOGF on the OTC Traded
What is the current price of Alpha Cognition Inc?
The current price of Alpha Cognition Inc is 0.3500
When was Alpha Cognition Inc last traded?
The last trade of Alpha Cognition Inc was at 11/04/24 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story